Inventor · disambiguated record
Robert H. Pierce
Also filed as: PIERCE ROBERT · PIERCE ROBERT CHRISTOPHER · PIERCE ROBERT H
10 granted patents·17 pending applications·233 citations·filing 1984–2023
88Inventor score
Files withONCOSEC MEDICAL INC10MERCK SHARP & DOHME8DOLLED-FILHART MARISA1MURTHY NIREN1PIERCE ROBERT H1
Top patents by PatentIndex Score
27 records- 0196US4634314AComposite marine riser systemVETCO OFFSHORE IND INC·Filed 1984·Granted Jan 6, 1987·144 cites·36 claims
- 0289US9709568B2Antibodies that bind to human programmed death ligand 1 (PD-L1)MERCK SHARP & DOHME·Filed 2013·Granted Jul 18, 2017·14 cites·8 claims
- 0388US4821804AComposite support column assembly for offshore drilling and production platformsPIERCE ROBERT H·Filed 1988·Granted Apr 18, 1989·56 cites·12 claims
- 0482US10426847B2Method for the treatment of malignanciesONCOSEC MEDICAL INC·Filed 2016·Granted Oct 1, 2019·7 cites·18 claims
- 0582US8252846B2Strategies for delivery of active agents using micelles and particlesMURTHY NIREN·Filed 2008·Granted Aug 28, 2012·6 cites·12 claims
- 0674US10241115B2Immunohistochemical proximity assay for PD-1 positive cells and PD-ligand positive cells in tumor tissueMERCK SHARP & DOHME·Filed 2014·Granted Mar 26, 2019·4 cites·18 claims
- 0768US11318305B2Systems and methods for improved tissue-sensing based electroporationONCOSEC MEDICAL INC·Filed 2016·Granted May 3, 2022·2 cites·23 claims
- 0865US11564999B2Method for the treatment of malignanciesONCOSEC MEDICAL INC·Filed 2019·Granted Jan 31, 2023·0 cites·14 claims
- 0960US2023272043A1Method for the treatment of malignanciesONCOSEC MEDICAL INC·Filed 2023·Application pending·0 cites
- 1059US2023001189A1Systems and methods for improved tissue-sensing based electroporationONCOSEC MEDICAL INC·Filed 2022·Application pending·0 cites
- 1158US2021062218A1Plasmid constructs for heterologous protein expression and methods of useONCOSEC MEDICAL INC·Filed 2020·Application pending·0 cites
- 1256US2021369813A9Modulating responses to checkpoint inhibitor therapyONCOSEC MEDICAL INC·Filed 2021·Application pending·0 cites
- 1355US11713467B2Plasmid constructs for heterologous protein expression and methods of useONCOSEC MEDICAL INC·Filed 2016·Granted Aug 1, 2023·0 cites·14 claims
- 1455US2023272082A1Anti-vista antibodies and uses thereofSENSEI BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1553US11193937B2Immunohistochemical assay for detecting expression of programmed death ligand 1 (PD-L1) in tumor tissueMERCK SHARP & DOHME·Filed 2017·Granted Dec 7, 2021·0 cites·4 claims
- 1651US2019209652A1Modulating responses to checkpoint inhibitor therapyONCOSEC MEDICAL INC·Filed 2017·Application pending·0 cites
- 1750US2016130574A1Methods of measuring gene expression in facs-sorted cellsMERCK SHARP & DOHME·Filed 2014·Application pending·0 cites
- 1848US2016084839A1Immunohistochemical assay for detecting expression of programmed death ligand 1 (pd-l1) in tumor tissueDOLLED-FILHART MARISA·Filed 2014·Application pending·0 cites
- 1946US2016312297A1Pd-l1 gene signature biomarkers of tumor response to pd-1 antagonistsMERCK SHARP & DOHME·Filed 2014·Application pending·0 cites
- 2046US2019219585A1Immunohistochemical proximity assay for pd-1 positive cells and pd-ligand positive cells in tumor tissueMERCK SHARP & DOHME·Filed 2019·Application pending·0 cites
- 2145US2002090363A1Sustained bioactive agent delivery device and methods of making and using the sameFiled 2001·Application pending·0 cites
- 2244US2016312295A1Gene signature biomarkers of tumor response to pd-1 antagonistsMERCK SHARP & DOHME·Filed 2014·Application pending·0 cites
- 2344US2016304969A1Ifn-gamma gene signature biomarkers of tumor response to pd-1 antagonistsMERCK SHARP & DOHME·Filed 2014·Application pending·0 cites
- 2443US2021349099A1Cancer biomarkers and methods of use thereofX4 PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2541US2004082554A1Neuroactive steroid derivatives and method of useFiled 2001·Application pending·0 cites
- 2636US2010062968A1Novel strategies for delivery of active agents using micelles and particlesPULENDRAN BALI·Filed 2006·Application pending·0 cites
- 2735US2018000895A1Method for the treatment of malignanciesONCOSEC MEDICAL INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Robert H. Pierce files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →